Somatostatin receptor expression in small cell lung cancer as a prognostic marker and a target for peptide receptor radionuclide therapy-Reference-Cited by-同舟云学术

Somatostatin receptor expression in small cell lung cancer as a prognostic marker and a target for peptide receptor radionuclide therapy

Published:2016-02-25 Issue:15 Volume:7 Page:20033-20040
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Lapa Constantin¹,Hänscheid Heribert¹,Wild Vanessa²,Pelzer Theo³,Schirbel Andreas¹,Werner Rudolf A.¹,Droll Sabine¹,Herrmann Ken¹,Buck Andreas K.¹,Lückerath Katharina¹

Affiliation:

1. Department of Nuclear Medicine, University Hospital Würzburg, 97080 Würzburg, Germany

2. Institute for Pathology, University of Würzburg, 97080 Würzburg, Germany

3. Department of Internal Medicine, University Hospital Würzburg, 97080 Würzburg, Germany

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting CXCR4 with [²¹²Pb/²⁰³Pb]-Pentixather Significantly Increases Overall Survival in Small Cell Lung Cancer;2024-09-11

2. Agonists, Antagonists and Receptors of Somatostatin: Pathophysiological and Therapeutical Implications in Neoplasias;Current Issues in Molecular Biology;2024-09-02

3. [177Lu]Lu DOTATOC PRRT with PARP inhibitors in small cell lung cancer;European Journal of Nuclear Medicine and Molecular Imaging;2024-08-27

4. Radiolabeled Somatostatin Analogs for Cancer Imaging;Seminars in Nuclear Medicine;2024-08

5. Combining [177Lu]Lu-DOTA-TOC PRRT with PARP inhibitors to enhance treatment efficacy in small cell lung cancer;European Journal of Nuclear Medicine and Molecular Imaging;2024-07-18